Massachusetts HD 5616: A communication from the Executive Office of Health and Human Services (see item 4000-0300 contained in Section 2 of Chapter 126 of the Acts of 2022) submitting the third quarterly report summarizing the projected total costs for the next fiscal year of pharmaceutical pipeline drugs identified by said office and expected to be made available for utilization within a 12-month period from the submission date of the filed report

Status: Placed on file (as of 2022-12-29)

State: Massachusetts · Session: 192nd · Bill: HD 5616

Sponsors: Executive Office of Health and Human Services

View Massachusetts HD 5616 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.